Compumedics Limited (AU:CMP) has released an update.
Compumedics Limited reports a record-breaking fiscal year with revenues soaring to $49.7 million, a 17% increase from the previous year, and a significant turnaround to $2.5 million EBITDA profit from a prior loss. The company’s growth momentum is attributed to robust sales orders, particularly in sleep diagnostics and new SaaS products like Somfit and Nexus 360, with the latter experiencing a 140% revenue jump. Looking ahead, Compumedics anticipates revenues exceeding $55 million for FY25, driven by ongoing investment in sales and marketing, particularly in the lucrative US market.
For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.
